Connell E B
Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA.
Contraception. 1999 Jan;59(1 Suppl):7S-10S. doi: 10.1016/s0010-7824(98)00130-9.
Although medical history has documented the desire to control fertility since ancient times, safe and effective contraception did not exist until this century and has not been equally available to all people. Strong moral sentiments, economic and social class factors, religious beliefs, familial and gender relations, and political as well as legal constraints have often limited the ability of physicians in favor of contraception to provide advice and methods of birth control to their patients. By the early 1900s, a constellation of factors--in particular, the large influx of poor immigrants, and feminist groups advocating women's rights--helped to move forward a birth-control movement in this country and abroad. In the early 20th century, Margaret Sanger became one of the most avid proponents of contraception in the United States. By 1950, she and Katharine McCormick had contracted with biologist Gregory Pincus to develop an effective birth control pill. A collaborative effort by Pincus and other researchers led to trials of the pill in Puerto Rico, Haiti, and Mexico between 1956 and 1957, which provided the basis for an application to the Food and Drug Administration for approval of the first oral contraceptive.
尽管医学史记载了自古以来人们控制生育的愿望,但安全有效的避孕方法直到本世纪才出现,而且并非所有人都能平等获得。强烈的道德观念、经济和社会阶层因素、宗教信仰、家庭和性别关系以及政治和法律限制,常常限制了支持避孕的医生向患者提供避孕建议和方法的能力。到20世纪初,一系列因素——特别是大量贫困移民的涌入,以及倡导妇女权利的女权主义团体——推动了国内外的节育运动。20世纪初,玛格丽特·桑格成为美国最热心的避孕支持者之一。到1950年,她和凯瑟琳·麦考密克与生物学家格雷戈里·平卡斯签约,研发一种有效的避孕药。平卡斯和其他研究人员的共同努力导致了1956年至1957年间在波多黎各、海地和墨西哥对这种药丸进行试验,这些试验为向食品药品监督管理局申请批准第一种口服避孕药提供了依据。